ClinicalTrials.gg
CompletedNCT06981221Updated Aug 14, 2026

PVI Predictors in Laparoscopic Hysterectomy

An observational study in Hysterectomy, PVI and Fluid Responsiveness, sponsored by Wonkwang University Hospital. Completed at 1 site in South Korea. Open to female participants aged 19 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Wonkwang University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
19 Years to 70 Years
Sex
Female
01

Study summary

This observational study investigates the predictors of Pleth Variability Index (PVI) changes in euvolemic patients undergoing laparoscopic-assisted vaginal hysterectomy (LAVH). The primary objective is to quantify changes in PVI (ΔPVI) across six intraoperative time points associated with positional shifts. Secondary objectives include identifying key predictors of significant PVI change (ΔPVI ≥ 5%), such as passive leg raising, Trendelenburg position, body mass index (BMI), and intraabdominal pressure. Additional variables including perfusion index, mean arterial pressure, bispectral index, skin temperature, age, and anesthetic agent will be evaluated as potential modulators. Findings aim to support individualized fluid management strategies in LAVH.

Read the detailed description

This prospective, single-center observational cohort study evaluates dynamic intraoperative changes in the Pleth Variability Index (PVI) in 50 adult female patients undergoing elective laparoscopically assisted vaginal hysterectomy (LAVH) at Wonkwang University Hospital.

After establishing euvolemia with a 500 mL Volulyte preload (Fresenius Kabi GmbH) over 30-50 minutes, no further intraoperative fluid boluses are given. Anesthesia is induced with propofol (2 mg/kg), fentanyl (1-2 μg/kg), and rocuronium (0.6 mg/kg), and maintained with sevoflurane or desflurane titrated to a bispectral index (BIS) of 40-60. Pneumoperitoneum is set at 12-15 mmHg, and positional maneuvers include 30° passive leg raising, 15° Trendelenburg, and 15° reverse Trendelenburg.

Monitoring devices and data acquisition:

  • **Masimo Radical-7** pulse oximeter (PVI, perfusion index [PI])
  • **Invasive arterial line** (mean arterial pressure [MAP])
  • **BIS sensor** (BIS)
  • **Skin temperature probe** (forearm, °C) calibrated pre-case

Measurements are recorded at six standardized time points (baseline; post-induction; post-passive leg raising; post-pneumoperitoneum; post-Trendelenburg; post-reverse Trendelenburg). Continuous waveforms are averaged over 30 s epochs.

Primary endpoint is the absolute change in PVI (ΔPVI) relative to baseline. Secondary analyses include:

  • Multivariable logistic regression for predictors of ΔPVI ≥ 5%
  • Multivariable linear regression for continuous ΔPVI prediction
  • Correlation analyses of ΔPVI with intraabdominal pressure (mmHg) and body mass index (kg/m²)
  • Sensitivity analysis of PI reliability (intraclass correlation coefficient) across skin temperature thresholds
  • Descriptive statistics for frequency of vasopressor (ephedrine) use

All analyses are performed using SPSS v29.0 with p \< 0.05 considered statistically significant (Bonferroni correction applied for repeated measures).

02

Conditions studied

  • Hysterectomy
  • PVI
  • Fluid Responsiveness
03

In context

Lead sponsor

Wonkwang University Hospital is the lead sponsor of 26 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 70 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Adult female patients aged 19 to 70 years with ASA physical status I-III who are scheduled to undergo elective laparoscopic-assisted vaginal hysterectomy (LAVH) at Wonkwang University Hospital. All participants are screened during routine preoperative consultations and provide written informed consent prior to enrollment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult females aged 19-70 years ( physical status I-III) scheduled for elective LAVH.

Exclusion criteria

Exclusion Criteria:

  • emergency surgery, severe cardiac or pulmonary disease, renal failure, pregnancy, or conditions contraindicating fluid administration. Participants were consecutively recruited during preoperative consultations.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (actual)
Patient registry
No

Interventions

  • DeviceMasimo Radical-7 Pulse Oximeter

    "PVI is continuously monitored using the Masimo Radical-7 pulse oximetry device to evaluate respiratory variation in the plethysmographic waveform amplitude during laparoscopic-assisted vaginal hysterectomy (LAVH). No fluid intervention is applied; device use is for observational measurement of fluid responsiveness."

    Also known as: PVI (Pleth Variability Index)

06

What researchers measure

Primary outcomes

  1. ΔPVI (Change in Pleth Variability Index)

    Absolute change in PVI (%) at each of six intraoperative time points relative to baseline.

    Time frame: Intraoperative period (~60-90 minutes)

Secondary outcomes

  1. Proportion of patients with significant ΔPVI ≥ 5%

    Percentage of participants exhibiting a ΔPVI ≥ 5% at any intraoperative time point.

    Time frame: At any of the six predefined intraoperative time points: • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg • End of surgery (within 60-90 minutes after induction of anesthesia)

  2. Effect of intraabdominal pressure on ΔPVI

    Correlation coefficient (r) between intraabdominal pressure (mmHg) and magnitude of ΔPVI.with magnitude of ΔPVI during pneumoperitoneum and Trendelenburg position. Multivariable linear regression is used.

    Time frame: At post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)

  3. Effect of body mass index on ΔPVI

    Correlation coefficient (r) between BMI (kg/m²) and magnitude of ΔPVI.measurements during LAVH. Data analyzed using subgroup comparison between stable and decreased skin temperature conditions.

    Time frame: ΔPVI measured at post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)

  4. Change in mean arterial pressure (MAP)

    Absolute change in MAP (mmHg) at the six predefined time points.

    Time frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

  5. Change in perfusion index (PI)

    Absolute change in PI (unitless) at the six predefined time points.

    Time frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

  6. Change in bispectral index (BIS)

    Absolute change in BIS (unitless) at the six predefined time points.

    Time frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

  7. Influence of skin temperature on PI reliability

    Difference in intraclass correlation coefficient of PI measurements between stable (≤ ± 1 °C) and decreased (\> 1 °C drop) skin temperature conditions.

    Time frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

  8. Frequency of vasopressor use

    Number and percentage of patients requiring ephedrine bolus due to MAP \< 70 mmHg during the observation period.

    Time frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)

07

Study locations

1 site
  • Wonkwang University School of Medicine Hospital
    Iksan, Jeollabuk-do 54538, South Korea
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06981221
Lead sponsor
Wonkwang University Hospital
Responsible party
Cheol Lee,MD,PhD, (Professor, Wonkwang University Hospital) — Principal investigator
First posted
May 20, 2025
Start date
Jul 1, 2026
Primary completion
Jul 10, 2026
Completion
Aug 12, 2026
Last update
Aug 14, 2026

Study contacts

Cheol Lee, M.D.,Ph.D
study director · Wonkwang University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion